echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Infection: Treatment with low-dose ethambutol below 12.5 mg/kg/day does not worsen clinical outcomes in M. pulmonary and M. intracellulare disease

    Infection: Treatment with low-dose ethambutol below 12.5 mg/kg/day does not worsen clinical outcomes in M. pulmonary and M. intracellulare disease

    • Last Update: 2022-03-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    The incidence and prevalence of nontuberculous mycobacteria (NTM) are increasing worldwide, with M.


     


     


    statistics

     



     

    Original source:

    Fumiya Watanabe.


    Low-dosage ethambutol, less than 12.
    5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study.
    Leave a

    comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.